Clinical tolerance 2008.
In 2008, three publications highlighted the transition of tolerance from experimental to experiential. These included the first study to both anticipate and reproducibly deliver human leukocyte antigen-disparate allograft survival without continuous immunosuppressive drug administration. The other two highlighted unique episodes of clinical tolerance. The results from these studies are summarized and discussed.
Kirk
Allan D
AD
Department of Surgery, Emory University, Atlanta, GA 30322, USA. adkirk@emory.edu
D000917:Antibody Formation; D006084:Graft Rejection / Q000517:prevention & control; D006085:Graft Survival; D006801:Humans; D007108:Immune Tolerance; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D018183:Transplantation Chimera; D014181:Transplantation Immunology; D023001:Transplantation Tolerance
D007166:Immunosuppressive Agents